Robert A. Farr
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert A. Farr.
Tetrahedron Letters | 2001
Robert J. Cregge; Robert A. Farr; Dirk Friedrich; Jos Hulshof; David A. Janowick; Scott Meikrantz; William A. Metz
Abstract The Knoevenagel condensation of arylacetonitriles with ethyl 4,6-dichloro-3-formyl-1 H -indole-2-carboxylate ( 2 ), followed by hydrolysis, provides a convenient entry into a series of analogs of MDL 105,519, 1 , a selective glycine site N -methyl- d -aspartate (NMDA) receptor antagonist. Surprisingly, the hydrolysis of the indole arylpropenenitriles terminates at the formation of the corresponding carboxamide and does not proceed further to the desired dicarboxylic acid. However, when the aryl substituent is pyridine, hydrolysis proceeds via an azepinoindole unique to this series, which upon further hydrolysis converts smoothly to the desired dicarboxylic acid analog.
Journal of Organic Chemistry | 1981
R. Marshall Wilson; Robert A. Farr; Donald J. Burlett
Archive | 1979
Robert A. Farr; Joseph E. Dolfini
Archive | 1982
Albert A. Carr; Robert A. Farr
Archive | 2004
Heinz W. Pauls; Suzanne Aldous; Gregory H. Merriman; Robert A. Farr; Adam W. Sledeski
Archive | 1996
Craig E. Thomas; Thomas L Fevig; Stephen M Bowen; Robert A. Farr; Albert A. Carr; David A. Janowick
Archive | 1995
Boyd L. Harrison; Philip L. Nyce; Robert A. Farr
Journal of Organic Chemistry | 1981
Robert A. Farr; Joseph E. Dolfini; Albert A. Carr
Archive | 2011
Steven Elenbaas; Robert A. Farr; John M. Kane
Archive | 1979
Albert A. Carr; Robert A. Farr